AstraZeneca Purges Two Respiratory Medicines in Big Day for Covis

[cafead]

via AstraZeneca’s respiratory portfolio is a little lighter as the British-Swiss pharmaceutical behemoth announced the offloading of two chronic obstructive pulmonary disease (COPD drugs) to fellow Swiss player Covis Pharma Group for $270 million.

article source